REQUEST A DEMO
Total
USD $0.00
Search more companies

Synteka Bio Inc. (South Korea)

Main Activities: Software Publishers
Full name: Synteka Bio Inc. Profile Updated: June 19, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Synteka Bio Inc. is a company in South Korea, with a head office in Daejeon. The enterprise currently operates in the Software Publishers sector. Synteka Bio Inc. was incorporated on September 15, 2009. There are currently 61 (2024) people employed by Synteka Bio Inc.. From the latest financial highlights, Synteka Bio Inc. reported a net sales revenue increase of 21627.29% in Q3C2025. Its’ total assets recorded a negative growth of 31.47%. The net profit margin of Synteka Bio Inc. increased by 37623.82% in 2025.

Headquarters
512, B-Dong, 187, Techno 2-Ro, Yuseong-Gu, Daejeon
Daejeon; Daejeon;

Contact Details: Purchase the Synteka Bio Inc. report to view the information.

Website: http://www.syntekabio.com

Basic Information
Total Employees:
Purchase the Synteka Bio Inc. report to view the information.
Outstanding Shares:
Purchase the Synteka Bio Inc. report to view the information.
Registered Capital:
Purchase the Synteka Bio Inc. report to view the information.
Financial Auditors:
Purchase the Synteka Bio Inc. report to view the information.
Incorporation Date:
September 15, 2009
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Subsidiaries
주)신테카바이오
Company Performance
Financial values in the chart are available after Synteka Bio Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
21627.29%
Total Operating Revenue
13448.81%
Operating Profit
-11.21%
EBITDA
24.93%
Net Profit/Loss for the Period
-352.66%
Total Assets
-31.47%
Total Equity
-59.09%
Operating Profit Margin
138465.68%
Net Profit Margin
37623.82%
Return on Equity (ROE)
-102.21%
Debt / Equity
80104%
Quick Ratio
-799.23%
Cash Ratio
-0.87%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?